How should the clinician most effectively prevent type 2 diabetes in the obese person at high risk?

被引:6
|
作者
Schwarz P.E.H. [1 ]
Li J. [1 ]
Lindström J. [1 ]
Bergmann A. [1 ]
Gruhl U. [1 ]
Saaristo T. [1 ]
Tuomilehto J. [1 ]
机构
[1] Department of Public Health, University of Helsinki, 00300 Helsinki
关键词
Metformin; Rosiglitazone; Lifestyle Intervention; Acarbose; Diabetes Prevention;
D O I
10.1007/s11892-007-0058-7
中图分类号
学科分类号
摘要
The dramatic increase in newly diagnosed cases of type 2 diabetes (T2D) has developed into a major public hearth concern worldwide. Conversely, several clinical studies have demonstrated that preventive efforts can significantly reduce the risk of developing diabetes. There is a clear consensus that action is needed to develop targeted community-based prevention programs and strategies for T2D. Currently, numerous prevention management concepts that can be implemented into clinical practice exist in various countries. Finland is the pioneer country in implementing community-wide diabetes prevention programs. Nevertheless, population-based nationwide strategies are still lacking in virtually all countries. We report on intervention strategies to prevent T2D in people with increased diabetes risk, as well as strategies on how to implement diabetes prevention programs into the real world of public health or clinical care. The implementation of managed prevention concepts will realistically help to improve the ability to prevent T2D in the public health framework. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码:353 / 362
页数:9
相关论文
共 50 条
  • [21] Determinants of lifestyle behavior change to prevent type 2 diabetes in high-risk individuals
    den Braver, N. R.
    de Vet, E.
    Duijzer, G.
    ter Beek, J.
    Jansen, S. C.
    Hiddink, G. J.
    Feskens, E. J. M.
    Haveman-Nies, A.
    INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY, 2017, 14
  • [22] Lifestyle advice by text messages helps prevent type 2 diabetes in high risk men
    Travasso, Cheryl
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
  • [23] Determinants of lifestyle behaviour change to prevent type 2 diabetes in high-risk subjects
    den Braver, N. R.
    de Vet, E. W. M.
    Duijzer, G.
    ter Beck, J.
    Jansen, S. C.
    Hiddink, G. J.
    Feskens, E. J. M.
    Haveman-Nies, A.
    DIABETOLOGIA, 2016, 59 : S143 - S144
  • [24] Preliminary testing of a program to prevent type 2 diabetes among high-risk youth
    Grey, M
    Berry, D
    Davidson, M
    Galasso, P
    Gustafson, E
    Melkus, G
    JOURNAL OF SCHOOL HEALTH, 2004, 74 (01) : 10 - 15
  • [25] Risk for Type 2 Diabetes Mellitus Person, Place, and Precision Prevention
    Adler, Nancy E.
    Prather, Aric A.
    JAMA INTERNAL MEDICINE, 2015, 175 (08) : 1321 - 1322
  • [26] Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese Adults
    Neeland, Ian J.
    Turer, Aslan T.
    Ayers, Colby R.
    Powell-Wiley, Tiffany M.
    Vega, Gloria L.
    Farzaneh-Far, Ramin
    Grundy, Scott M.
    Khera, Amit
    McGuire, Darren K.
    de Lemos, James A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (11): : 1150 - 1159
  • [27] Dietary patterns and the risk of type 2 diabetes in overweight and obese individuals
    Florianne Bauer
    Joline W. J. Beulens
    Daphne L. van der A
    Cisca Wijmenga
    Diederick E. Grobbee
    Annemieke M. W. Spijkerman
    Yvonne T. van der Schouw
    N. Charlotte Onland-Moret
    European Journal of Nutrition, 2013, 52 : 1127 - 1134
  • [28] Soluble transferrin receptor and risk of type 2 diabetes in the obese and nonobese
    Fernandez-Cao, Jose C.
    Arija, Victoria
    Aranda, Nuria
    Basora, Josep
    Diez-Espino, Javier
    Estruch, Ramon
    Fito, Montse
    Corella, Dolores
    Salas-Salvado, Jordi
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 (03) : 221 - 230
  • [29] Metformin in the Treatment of Obese Children and Adolescents at Risk of Type 2 Diabetes
    Kendall, Deborah L.
    Amin, Rakesh
    Clayton, Peter E.
    PEDIATRIC DRUGS, 2014, 16 (01) : 13 - 20
  • [30] Metformin in the Treatment of Obese Children and Adolescents at Risk of Type 2 Diabetes
    Deborah L. Kendall
    Rakesh Amin
    Peter E. Clayton
    Pediatric Drugs, 2014, 16 : 13 - 20